Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling

Published:2022-02 Issue: Volume:176 Page:106057
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Liu Jiani,Pi Zixin,Xiao Yangfan,Zeng Zhuotong,Yu Jiangfan,Zou Puyu,Tang Bingsi,Qiu Xiangning,Tang Rui,Shi Yaqian,Xiao Rong

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference41 articles.

1. Systemic sclerosis;Denton;Lancet,2017

2. Update of EULAR recommendations for the treatment of systemic sclerosis;Kowal-Bielecka;Ann. Rheum. Dis.,2017

3. 25 Years of proton pump inhibitors: a comprehensive review;Strand;Gut Liver,2017

4. Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor;Hammond;PLoS One,2019

5. Esomeprazole ameliorates CCl(4) induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers;Eltahir;Biomed. Pharmacother.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silica's silent threat: Contributing to skin fibrosis in systemic sclerosis by targeting the HDAC4/Smad2/3 pathway;Environmental Pollution;2024-08

2. The Role of Aryl Hydrocarbon Receptor in the Pathogenesis and Treatment of Psoriasis;Journal of Cutaneous Medicine and Surgery;2024-03-18

3. Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases;Pharmacology & Therapeutics;2024-01

4. Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism;Biochemical and Biophysical Research Communications;2023-11

5. ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model;Arthritis Research & Therapy;2023-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3